Chronic lung sufferers call for an end to stand-off on access to ’life-changing’ drug

Campaigners at a Respreeza funding protest in February

Patients with genetic emphysema are calling for an end to the current stand-off on what they claim is a life-changing drug.

They will hold a vigil today before the HSE meets with pharmaceutical company CSL Behring to discuss access to Respreeza.

21 patients with the Alpha 1 condition were previously on a clinical trial for the drug, before a row erupted over who should administer it.

Patients say the therapy is still available however the drug company is not funding its infusion after the HSE said it would not grant reimbursement.

The drug faces a lengthy approval period due to its cost.

In September, campaigners said that losing access to the drug meant that some patients "could be dead in six months".

More in this Section

Shivs and Shanks: Exhibition of improvised weapons goes on display on Spike Island

Prisons seek to ease fears over backlog of sex offenders for treatment programme

Cystic fibrosis patients call for new hospital facilities

Update: Body found in search for missing Ruth Maguire in Carlingford


Lifestyle

All set for summer with a ray of festivals and gigs to chose from

A growing awareness to grow, cook and eat

Making Cents: Making their day special without breaking the bank

More From The Irish Examiner